KEEP

zep

Keep Word Bms

Simplifying Treatment
with KEEP.

Real-world insights and personalized support for complex patient journeys.

Sales Img 2

Discover how KEEP can help Zeposia patients thrive.

KEEP’s Fit for the Therapy

KEEP is designed to meet the unique challenges faced by patients, helping manage their daily dosing regimens seamlessly integrating into patients’ lives, improving adherence and reducing treatment burdens. In tandem, KEEP supports pharma, unlocking deep insights into the patient and supporter experience.

Sales Check Sales Img 2

Dose Due Notification

Sales Img 3

passively capture dosing events

Sales Img 4

real time insights for manufacturers and health system partners

Patient Challenges &
KEEP’s Solution

Key Challenge:

Lack of real-world experience and actionable insights. Current data is delayed or incomplete.

Sales Img 5

KEEP’s Solution:
KEEP passive medication tracking provides daily, real-time insights on dosing behavior, the why behind experiences, and measures the impact of interventions.

Key Challenge:
Risk of disruption with initial dose escalation regimen.

Sales Img 6

KEEP’s Solution:
Personalized treatment plans aligned to the initial 7 day escalation schedule – reminders and notifications to keep patients on track. If 1 dose is missed, we know.

Key Challenge:
Missed doses causing patients to re-enter the initiation phase of treatment.

Sales Img 7

KEEP’s Solution:
Post initiation phase, tracking the daily dosing regimen of patients – classifying their dosing behavior – and escalation if treatment is interrupted.

Real World Experience (RWE-X) Perspective

While real-world data captures how patients take their medication, KEEP goes beyond that with Real World Experience (RWE-X). RWE-X captures the true, human experience of living with complex conditions, giving pharma companies insights into how patients navigate their day-to-day lives with their treatment. This deeper understanding allows healthcare providers to offer more personalized and timely support, ultimately improving outcomes and patient satisfaction.

Box1 RWE-X captures the “why” behind the data

Box6 70% of patients face challenges beyond what data can capture

Box4 75% of patients want personalized support with their medication journey

Box3 Empathy driven insights lead to better care and a stronger connection between patients and pharma

Box5 2.2 daily interactions demonstrate KEEP’s seamless integration into patients’ routines.

KEEP has proven success in driving patient adherence.

Adherence rates

Opt-in rate among patients

Reduction in overall healthcare costs and improved outcomes

Download Our Case Studies

Sign up for your KEEP box

Our patient support team will confirm your eligibility and arrange delivery. Reach out and mention the program name on this page.

Phased Deployment Approach

Group 1868

Pilot Phase
In the initial pilot phase, KEEP will be deployed to a select group of patients on Zeposia to demonstrate its impact on adherence and patient engagement.

Group 1867

Evaluation & Scaling
Following the pilot, we’ll assess the results and work with your team to fine-tune KEEP’s features to ensure maximum benefit for all patients on Zeposia.

Group 1897

Full-Scale Rollout
Once the pilot is complete, KEEP will be rolled out across all Zeposia patients, helping you deliver improved adherence and engagement at scale.

KEEP works seamlessly with Zeposia to support patient adherence, providing real-time insights and personalized support that make a difference in the day-to-day lives of patients.

Discover how KEEP can help Zeposia patients thrive.